In February 2023, the UroFill® technique arrived in Brazil with the goal of being a viable option for a procedure that was heavily questioned by Brazilian urology and andrology: penile girth enhancement. Developed and perfected by American urologist Paul Perito, the world’s leading penile prosthesis implanter and a global reference in male sexual health, UroFill® quickly won over Brazilian urology and andrology with its approach to the subject, offering safety, efficacy, evidence, unparalleled case studies, and reproducibility, inaugurating a new era of reliability for the procedure.
Three years later and with more than 100 certified urologists in the country, it is safe to say that UroFill® is the reference technique for penile girth enhancement in Brazil. “The number one differentiating factor of the UroFill® technique is its transparency,” says André Pedrosa, Founder and CEO of Uroconic, the official distributor of UroFill® in Brazil. “Registrations, patents, studies, certifications, updates, post-procedure support. UroFill® is the only technique on the market that truly supports doctors and patients from start to finish. UroFill® takes penile girth enhancement seriously,” he adds.
Under the marketing and sales management of Camila Marques since January 2024 and May 2025, respectively, UroFill® underwent a transformation in its communication and sales methods during its first three years in Brazil. “Identifying that the sales model that brought us to 2024 wouldn’t take us further was essential to ensuring the business’s sustainability. UroFill® sales in Brazil became more efficient,” she states. In addition to the change in the sales model, Marques played a fundamental role in generating value for the brand in Brazil, elevating it to a market benchmark. “For years, penile girth enhancement was stigmatized by the absence of rigorous methods and empirical evidence, relying on opinions, isolated experiences, or subjectivity. UroFill® was the answer urology needed to incorporate the procedure into its daily practice,” says Marques. “UroFill® is not a fad or a passing trend. It represents almost two decades of constant dedication to penile girth enhancement taken seriously. All of this needed to be reflected in our communication. From the value proposition of the certification to the way we communicate with doctors and patients, everything has been transformed. The numbers show that we are on the right track,” she concludes.
The Legacy of UroFill®
UroFill® inaugurated its fourth year in Brazil in February 2026 and still has many plans for the country, the third largest aesthetic market in the world in terms of number of procedures.
“What mark does UroFill® wants to leave in Brazil? That is the question that will guide us into the future. The answer lies in the genesis of the technique,” says Pedrosa. “Standardization, safety, efficacy – non-negotiable values for its creator [Dr. Paul Perito] and recently reinforced by him in an article he authored and published in October 2025 in The Journal of Sexual Medicine under the title, “Standardization, safety, and the future of cosmetic penile enhancement: Perspective on Cosmetic penile enhancement procedures: An SMSNA position statement” – will be the pillars of this great legacy. UroFill® will continue its journey through its well-known enduring quality, reputation, and impact, built on solid values, purpose, and exceptional experiences for doctors and patients, always evolving while preserving its core identity,” concludes Marques.
Uroconic is responsible for UroFill®’s entry into the Brazilian market, acting in marketing and sales execution since its launch.
Image: André Pedrosa and Camila Marques with UroFill® executives Dr. Paul Perito and Dr. Alfredo Suárez-Sarmiento, Jr. at the WMSM 2024.
Want to know more about how we can support your healthcare business?
Contact us by email at contact.us@uroconic.com or through the form below.
Tags: news, penile girth enhancement, penile harmonization, UroFill®